Edwards Lifesciences Corporation (EW) /

The debt of Edwards Lifesciences Corporation over the past 10 years

Chart Edwards Lifesciences Corporation: liquid cash, total debt, net cash, fiscal 2016–2025 Open the chart →

At the end of fiscal 2025, the latest fiscal year on file, Edwards Lifesciences Corporation had liquid cash of $4.23B and total debt of $598.3M: net cash of $3.63B. It had more liquid cash than debt at all 10 year-ends shown. Total debt was highest at the end of fiscal 2017 ($1.04B) and lowest at the end of fiscal 2018 ($593.8M).

Year by year

Fiscal yearLiquid cashTotal debt*Net cash*
2025ended Dec 31, 2025$4.23B*$598.3M$3.63B
2024ended Dec 31, 2024$3.98B*$597.7M$3.38B
2023ended Dec 31, 2023$1.63B*$597M$1.04B
2022ended Dec 31, 2022$1.22B*$596.3M$619M
2021ended Dec 31, 2021$1.47B*$595.7M$871.1M
2020ended Dec 31, 2020$1.4B*$595M$807.6M
2019ended Dec 31, 2019$1.52B*$594.4M$922.5M
2018ended Dec 31, 2018$956.5M*$593.8M$362.7M
2017ended Dec 31, 2017$1.34B*$1.04B$301.1M
2016ended Dec 31, 2016$1.27B*$822.3M$448.8M

Fiscal years as Edwards Lifesciences Corporation reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on Edwards Lifesciences Corporation

Companies of a similar size

Not investment advice. This page shows what Edwards Lifesciences Corporation filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.